(UPDATED) Swift initiation of rhythm-control therapy in patients with recently diagnosed atrial fibrillation in the setting of other cardiovascular conditions reduced the risk of CV events as compared ...

All five trials have shown no improvement in mortality or morbidity by aggressively controlling rhythm with antiarrhythmic drugs. The consistency of these findings is truly remarkable if one considers ...

The management of patients with atrial fibrillation involves three main areas: anticoagulation, rate control and rhythm control. Importantly, these are not mutually exclusive of each other.

Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care. The beneficial ...

A sub-study analysis of the EAST—AFNET 4 trial revealed how genetic risk for atrial fibrillation (AF) and stroke interacts with early rhythm control therapy: Early rhythm control reduces ...

Trial findings challenge concerns over early rhythm control in patients with mild to moderate chronic kidney disease (CKD) and recent atrial fibrillation.

Early rhythm control with ablation or antiarrhythmic drugs is associated with a lower risk of adverse cardiovascular outcomes compared with rate control in patients with newly diagnosed atrial ...

Montreal, QC - A large population-based study suggests that rhythm control may be more effective than rate control at reducing mortality in atrial fibrillation (AF) patients over the long run [1].

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to new results. Patients with newly diagnosed atrial fibrillation benefit from early rhythm ...

The choice of management strategy in patients with recent-onset AF does not affect clinical outcomes, but does influence the likelihood of progression to permanent AF, according to data from an ...

Please provide your email address to receive an email when new articles are posted on . In patients younger than 75 years with atrial fibrillation and concomitant CV conditions, an early rhythm ...